Advocating for a world where intellectual
property law serves the public interest.
[Matheus Z. Falcão, Mariana Gondo and Ana Carolina Navarrete] Competition law may play an important role in drug pricing control by containing high prices derived from economic violations. Since the use of competition tools is not limited by the TRIPS Agreement or other international binding disciplines, there is ample policy room to explore how countries, especially in the Global South,
[Teresa Hackett] EIFL supports the proposal at the WTO by South Africa and India, backed by more than 100 countries, to temporarily waive IP rights on COVID-19 vaccines and treatments... From a copyright and research perspective, there are three key components for the prevention, containment and treatment of COVID-19. First, researchers must be allowed to do the research. Second, researchers
[Paul Keller] ... On Monday YouTube published the first edition of its Copyright Transparency Report. The report that covers copyright enforcement actions on the platform for the period from January to June of this year provides much needed insights into how YouTube’s various copyright management systems function... So what can we learn from this first copyright transparency report? The overall
The TRIPS Waiver: Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19
This research event focused upon the geopolitical debate over access to essential medicines during the coronavirus public health crisis. I brought together researchers, experts and scholars working in the field of access to essential medicines — ranging through the disciplines of intellectual property, public health law, human rights, international law, and trade law.
[Raffaele Danna, Arianna Martinelli and and Alessandro Nuvolari] The literature on negative intellectual property (IP) spaces investigates how innovation and creativity are incentivized in sectors where IP law does not apply, or is not enforced. This contribution seeks to offer an introduction to the concept of negative IP, the debates surrounding it, and the case studies of negative IP developed
[Cynthia Ho] An under-examined issue during the COVID-19 crisis is the potential liability of countries under investment agreements for taking steps to mitigate COVID issues. This Policy Brief provides an overview of how countries may be liable to companies for taking domestic action to protect public health, including pre-COVID claims related to Intellectual Property (IP), as well as possible claims
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources